Breakthrough Chemistry, Inc. (BKTH)
0.208
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Breakthrough Chemistry SG&A Expense (TTM) : 0.073M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.073M |
| March 31, 2026 | 0.0404M |
| December 31, 2025 | 0.1028M |
| September 30, 2025 | 0.1243M |
| June 30, 2025 | 0.1299M |
| March 31, 2024 | 0.1509M |
| December 31, 2023 | 0.115M |
| September 30, 2023 | 0.1076M |
| June 30, 2023 | 0.1109M |
| March 31, 2023 | 0.1205M |
| December 31, 2022 | 0.0852M |
| September 30, 2022 | 0.0883M |
| June 30, 2022 | 0.0922M |
| March 31, 2022 | 0.0766M |
| December 31, 2021 | 0.0708M |
| September 30, 2021 | 0.0559M |
| June 30, 2021 | 0.0464M |
| March 31, 2021 | 0.0331M |
| December 31, 2020 | 0.0071M |
| September 30, 2020 | 0.0048M |
| June 30, 2020 | 0.0018M |
| October 31, 2014 | 0.0001M |
| July 31, 2014 | 0.0301M |
| April 30, 2014 | 0.4601M |
| January 31, 2014 | 0.46M |
| Date | Value |
|---|---|
| October 31, 2013 | 0.46M |
| July 31, 2013 | 0.43M |
| April 30, 2013 | 0.00 |
| January 31, 2013 | 0.00 |
| October 31, 2012 | 0.0331M |
| July 31, 2012 | 0.0643M |
| April 30, 2012 | 0.2913M |
| January 31, 2012 | 0.3396M |
| October 31, 2011 | 0.5612M |
| July 31, 2011 | 0.6138M |
| April 30, 2011 | 0.6994M |
| January 31, 2011 | 0.7961M |
| October 31, 2010 | 0.7306M |
| July 31, 2010 | 0.8142M |
| April 30, 2010 | 0.5016M |
| January 31, 2010 | 0.4902M |
| October 31, 2009 | 0.4184M |
| July 31, 2009 | 0.3979M |
| April 30, 2009 | 0.3979M |
| January 31, 2009 | 0.4089M |
| October 31, 2008 | 0.4793M |
| July 31, 2008 | 0.4213M |
| April 30, 2008 | 0.4213M |
| January 31, 2008 | 0.3563M |
| October 31, 2007 | 0.2824M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Cardiac Biotech Solutions, Inc. | 0.4266M |
| Precision Optics Corp., Inc. | 7.708M |
| Petros Pharmaceuticals, Inc. | 3.398M |
| RxSight, Inc. | 117.31M |
| Vyome Holdings, Inc. | 2.683M |